Extracorporeal shockwave lithotripsy (ESWL)
ProcedureESWL, two treatments with an interval of two days or three weeks.
NCT Number: NCT07421843
Extracorporeal shockwave lithotripsy (ESWL) is one way to treat renal stones. In this clinical trial our goal is to evaluate if two ESWL the same week is equal good and safe to two ESWL 3 weeks regarding renal stones 8-15 mm.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Department of Urology, Helsingborg, Sweden
All patients with a renal stone 8-15 mm are asked to participate. If they give consent they are randomized to ESWL with an interval of 2 days or 3 weeks. Data regarding age, gender, stone size, Hounsfield unit, skin to stone distance, urine culture, results from the follow up CT and need for auxillary interventions are extraced from the medical records.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients with a renal stone 8-15 mm who are planned for intervention -
Exclusion criteria
Those who decline to participate, those who are put under guardianship or is less than 18 years old.
-
ESWL, two treatments with an interval of two days or three weeks.
Time frame: From enrollment until closure
Number of days from the day the treatment starts until the end of follow up.
Time frame: From enrollment until closure
Are there any differences in complications
Time frame: From enrollment until closure.
Number of participants who are stone free at the follow up after two ESWL. Stone status will be assessed with computer tomography.
Time frame: From enrollment until closure
Participant´s experiences, quality of life questionnaire. Most questions were structured as yes/ no items or included three to four predefined response options.
Region Skane
Other
Double Extracorporeal Shockwave Lithotripsy for Renal Stones.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04430426
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06783946
Anxiety Postoperative, Calculi
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07176026
Calculi, Female Urogenital Diseases
Helsingborg, Sweden
View Trial DetailsNCT07718802
Calculi, Female Urogenital Diseases
Philadelphia, Pennsylvania, United States
View Trial Details